Carisma Therapeutics Inc. (CARM) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

Carisma Therapeutics Inc. (CARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.91 Million. See how much free cash does Carisma Therapeutics Inc. generate to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$1.91 Million
USD

Capital Expenditures

$0.00
USD

Carisma Therapeutics Inc. Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for Carisma Therapeutics Inc. across 1 annual periods. For the full cash flow conversion analysis, see CARM cash flow metrics.

Annual Cash Flow Reinvestment Rate for Carisma Therapeutics Inc. (2016–2016)

Year-by-year capital reinvestment analysis for Carisma Therapeutics Inc.. See CARM financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 0.00x $0.00 $2.62 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow